Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Nephrology

Starting Your Journey with dRTA

At a Glance

Distal renal tubular acidosis (dRTA) is a rare kidney condition that causes acid to build up in the blood and urine to remain too alkaline. Consistent alkali treatment can restore balance, support growth and bones, and reduce future kidney stone risk.

Receiving a diagnosis of distal renal tubular acidosis (dRTA) often marks the end of a long and confusing search for answers. For many families, this “diagnostic odyssey” involves months or even years of navigating unexplained symptoms, such as a child not growing as expected (failure to thrive) or recurring kidney stones in an adult [1][2].

It is normal to feel a mix of emotions: relief that the problem has a name, fear about what it means for the future, or overwhelm at the thought of a long-term condition [3]. Whether you are a parent seeing your child struggle or an adult discovering dRTA alongside another health issue, your experience is valid. This page provides a foundation for understanding the biology of dRTA and what to expect as you move forward.

What is Distal RTA?

At its core, dRTA is a breakdown in the kidney’s regulation system for acid. Your body constantly produces acid as it breaks down food and builds muscle. To keep your blood healthy, your kidneys must filter this acid out of the blood and move it into your urine.

In dRTA, the specific cells responsible for this “acid-pumping” job—called alpha-intercalated cells—are not working correctly [4]. These cells live in the distal tubule, the final section of the kidney’s filtering units.

When these cells fail:

  • Acid builds up in the blood: This is called metabolic acidosis [5].
  • Urine stays too alkaline: Because the acid isn’t being pumped out, the urine remains “basic” or alkaline (typically with a pH above 5.5) when it should be acidic [6][7].
  • Mineral balance is disrupted: The body may lose too much potassium or calcium, which can lead to muscle weakness, bone issues, or kidney stones [5][8].

Clearing Up a Common Misunderstanding

It is important to know that metabolic acidosis is not caused by your diet. It is a structural and functional issue with how your kidneys handle the body’s internal chemistry [9]. You did not cause this by eating “acidic” foods like citrus or soda, and you cannot cure it by simply changing what you eat [9][10]. While diet can play a small role in supporting medical treatment, the primary cause of dRTA is either a genetic “instruction error” in the cells or an outside factor, like an autoimmune disease, that has damaged those cells [11][12].

A Rare and Diverse Condition

Distal RTA is considered a rare disease, estimated to affect fewer than 1 in 100,000 people depending on the specific population [13]. Because it is so rare, the experience can look very different from person to person:

  • In Children: It is usually a genetic (inherited) condition. It often shows up in infancy with symptoms like vomiting, dehydration, or a slowdown in growth [9][2].
  • In Adults: It is more commonly a “secondary” condition, meaning it is caused by something else. The most frequent cause in adults is Sjögren syndrome, an autoimmune disease, but it can also be caused by certain medications or other kidney issues [9][14].

The Path Forward: Treatment and Outcomes

The most important thing to know about dRTA is that it is highly treatable. While it is usually a chronic condition, the goal of treatment is to allow you or your child to live a full, active life.

The standard treatment is alkali therapy (usually in the form of potassium citrate or sodium bicarbonate) [15]. This medicine acts like a “buffer,” neutralizing the acid in the blood that the kidneys can’t remove.

When treatment is started early and maintained consistently:

  • Growth can resume: Children who have fallen behind in height often see a “catch-up” period once their blood chemistry is balanced [15][16].
  • Kidney stone risk is reduced: Keeping the blood and urine chemistry in a healthier range reduces the risk of new stones forming and helps prevent further calcium deposits (nephrocalcinosis) in the kidney tissue (though existing stones and deposits may not fully dissolve) [15][17].
  • Bone health is protected: Proper acid balance prevents the body from “stealing” minerals from the bones to buffer blood acid, reducing the risk of rickets or fractures [15][16].

Consistency is key. Research shows that while about half of patients achieve excellent control of their lab numbers, many struggle with the practical side of treatment, such as the taste of the medicine or the need for multiple doses throughout the day [18][19]. If you find the treatment difficult to manage, talk to your doctor—there are often different formulations or schedules that can help. For more information on navigating the emotional and practical side of this journey, see the section on Staying on Track: Monitoring and Daily Life.

Common questions in this guide

What is distal renal tubular acidosis (dRTA)?
dRTA is a rare kidney condition in which cells in the distal tubules cannot move enough acid from the blood into the urine. Acid can therefore build up in the blood while the urine stays too alkaline. This can affect potassium and calcium balance and increase the risk of kidney stones, weak bones, or growth problems.
Why did I or my child develop dRTA, and can food cause it?
In children, dRTA is often inherited; in adults, it is more often caused by another condition, such as Sjögren syndrome, certain medications, or other kidney problems. It is not caused by eating acidic foods or by something you did. Diet may support treatment, but it cannot correct the underlying kidney problem.
How is distal RTA treated?
The standard treatment is alkali therapy, such as potassium citrate or sodium bicarbonate. These medicines help neutralize the acid that the kidneys cannot remove and restore healthier blood and urine chemistry. Taking treatment consistently and discussing taste, stomach problems, or dosing challenges with the care team can make it easier to continue.
Can dRTA affect a child's growth or cause kidney stones?
Yes. Untreated or poorly controlled dRTA can slow growth, weaken bones, and contribute to kidney stones or calcium deposits in kidney tissue. With early, consistent treatment, children may catch up in growth, and treatment can reduce new stones and help protect bone health, although existing stones or deposits may not completely disappear.
How can I tell whether dRTA treatment is working?
Your clinician will use blood and urine chemistry, along with changes in symptoms and, for children, growth, to assess control. Lower risk of new kidney stones and stable bone and kidney health are also important goals. Ask what results should improve, how often testing is needed, and whether the treatment dose or schedule should be adjusted.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Distal renal tubular acidosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my/my child's lab results, is this a primary genetic condition or secondary to another health issue?
  2. 2.How has the delay in diagnosis affected my/my child's long-term kidney health or growth?
  3. 3.What specific type of alkali treatment are you recommending, and how can we manage potential taste or stomach issues?
  4. 4.Are there specific extra-renal symptoms, like hearing loss, that we need to screen for based on the suspected cause?
  5. 5.Can you refer us to a genetic counselor or a social worker who specializes in rare kidney diseases?
  6. 6.How will we know if the treatment is working well enough to reduce the risk of future kidney stones?

References

References (19)
  1. 1

    Rare Renal Disease in Macedonia - An Update.

    Tasic V, Gucev Z, Polenakovic M

    Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 2017; (38(3)):63-69.

    PMID: 29668475
  2. 2

    [Epidemiological, clinical and evolutionary particularities of primary distal tubular acidosis in Tunisian children].

    Hammi Y, Charfi H, Ferjani M, et al.

    Nephrologie & therapeutique 2022; (18(6)):541-548 doi:10.1016/j.nephro.2022.03.006.

    PMID: 36216732
  3. 3

    Caregiver Experience in Pediatric Dialysis.

    Wightman A, Zimmerman CT, Neul S, et al.

    Pediatrics 2019; (143(2)) doi:10.1542/peds.2018-2102.

    PMID: 30696758
  4. 4

    Intercalated Cell Depletion and Vacuolar H+-ATPase Mistargeting in an Ae1 R607H Knockin Model.

    Mumtaz R, Trepiccione F, Hennings JC, et al.

    Journal of the American Society of Nephrology : JASN 2017; (28(5)):1507-1520 doi:10.1681/ASN.2016020169.

    PMID: 27932475
  5. 5

    Hypokalemic Distal Renal Tubular Acidosis.

    Vallés PG, Batlle D

    Advances in chronic kidney disease 2018; (25(4)):303-320 doi:10.1053/j.ackd.2018.05.003.

    PMID: 30139458
  6. 6

    The pathophysiology of distal renal tubular acidosis.

    Wagner CA, Unwin R, Lopez-Garcia SC, et al.

    Nature reviews. Nephrology 2023; (19(6)):384-400 doi:10.1038/s41581-023-00699-9.

    PMID: 37016093
  7. 7

    Hereditary distal renal tubular acidosis: Genotypic correlation, evolution to long term, and new therapeutic perspectives.

    Gómez-Conde S, García-Castaño A, Aguirre M, et al.

    Nefrologia 2021; (41(4)):383-390 doi:10.1016/j.nefroe.2021.09.004.

    PMID: 36165107
  8. 8

    Sjogren's Syndrome in the Mask of Hypokalemia: A Case Report.

    Sodari KB, Basnet P, Adhikari K

    JNMA; journal of the Nepal Medical Association 2024; (62(280)):841-843 doi:10.31729/jnma.8836.

    PMID: 40654398
  9. 9

    Distal renal tubular acidosis: genetic causes and management.

    Soares SBM, de Menezes Silva LAW, de Carvalho Mrad FC, Simões E Silva AC

    World journal of pediatrics : WJP 2019; (15(5)):422-431 doi:10.1007/s12519-019-00260-4.

    PMID: 31079338
  10. 10

    Deficient acid handling with distal RTA in the NBCe2 knockout mouse.

    Wen D, Yuan Y, Cornelius RJ, et al.

    American journal of physiology. Renal physiology 2015; (309(6)):F523-30 doi:10.1152/ajprenal.00163.2015.

    PMID: 26109087
  11. 11

    Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis.

    Mohebbi N, Wagner CA

    Journal of nephrology 2018; (31(4)):511-522 doi:10.1007/s40620-017-0447-1.

    PMID: 28994037
  12. 12

    Recurrent Hypokalemia leading to Flaccid Quadriparesis: A Renal or Connective Tissue Disorder.

    Bansal N, Kumar PA, Agarwal MP, Aggarwal A

    Puerto Rico health sciences journal 2017; (36(4)):240-242.

    PMID: 29220070
  13. 13

    Clinical and molecular mechanistic insights into the WDR72 mutation.

    Gupta A, Elangovan A, Singh R, Wander A

    BMJ case reports 2025; (18(9)) doi:10.1136/bcr-2025-265122.

    PMID: 40953848
  14. 14

    Hypokalemic quadriplegia in Sjogren's syndrome: A case report.

    Mehdipour Dalivand M, Abdolazimi R, Alikhani M

    Clinical case reports 2024; (12(8)):e9227 doi:10.1002/ccr3.9227.

    PMID: 39091614
  15. 15

    Primary Distal Renal Tubular Acidosis: Toward an Optimal Correction of Metabolic Acidosis.

    Medina E, Ariceta G, Batlle D

    Clinical journal of the American Society of Nephrology : CJASN 2024; (19(9)):1212-1222 doi:10.2215/CJN.0000000000000535.

    PMID: 38967973
  16. 16

    6-year treatment follow-up with an extended-release alkaline formulation (Sibnayal®) in primary distal renal tubular acidosis.

    Bertholet-Thomas A, De Mul A, Bernardor J, et al.

    Orphanet journal of rare diseases 2025; (20(1)):431 doi:10.1186/s13023-025-03953-4.

    PMID: 40804680
  17. 17

    Renal cysts in WDR72-associated distal renal tubular acidosis: expanding the phenotypic spectrum.

    Vallabhaneni P, Dawman L, Bhatia A, et al.

    CEN case reports 2026; (15(5)).

    PMID: 42545441
  18. 18

    Treatment and long-term outcome in primary distal renal tubular acidosis.

    Lopez-Garcia SC, Emma F, Walsh SB, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2019; (34(6)):981-991 doi:10.1093/ndt/gfy409.

    PMID: 30773598
  19. 19

    Recent Developments in the Treatment of Pediatric Distal Renal Tubular Acidosis.

    Boyer O, Ould Rabah M, Preka E

    Paediatric drugs 2024; (26(6)):649-657 doi:10.1007/s40272-024-00651-9.

    PMID: 39325135

This page explains distal renal tubular acidosis (dRTA), its causes, and treatment for educational purposes only; it does not replace medical advice. A qualified clinician should interpret your or your child's laboratory results and tailor care to your situation.